Search research articles
Contact Us
Filters
Showing results (11-20 of 241) with videos related to
Page
of 25
Sort By:
Prion
|
October 25, 2012
Grey matter lesions in MS: from histology to clinical implications
Massimiliano Calabrese, Alice Favaretto, Valeria Martini, et al.
Expert Review of Neurotherapeutics
|
March 8, 2011
Cortical pathology and cognitive impairment in multiple sclerosis
Massimiliano Calabrese, Francesca Rinaldi, Paola Grossi, et al.
JAMA
|
October 30, 2025
Screening for Hepatitis C in Emergency Departments
Paolo Gallo, Umberto Vespasiani-Gentilucci, Raffaele Antonelli-Incalzi
Frontiers in Neurology
|
June 3, 2021
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
Monica Margoni, Francesca Rinaldi, Paola Perini, et al.
Expert Review of Neurotherapeutics
|
October 22, 2011
The puzzle of multiple sclerosis: gray matter finds its place
Massimiliano Calabrese, Francesca Rinaldi, Valentina Poretto, et al.
Journal of Neurology
|
March 12, 2004
The clinical impact of interferon beta antibodies in relapsing-remitting MS
Paola Perini, Massimiliano Calabrese, Giovanni Biasi, et al.
Biochemical and Biophysical Research Communications
|
November 13, 2017
Upregulation of eIF6 inhibits cardiac hypertrophy induced by phenylephrine
Nicla Romano, Sara Ricciardi, Paolo Gallo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 4, 2008
Cyclophosphamide-based combination therapies for autoimmunity
Paola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.
Expert Opinion on Drug Safety
|
March 21, 2007
The safety profile of cyclophosphamide in multiple sclerosis therapy
Paola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.
Neurology
|
October 5, 2012
Severe relapses under fingolimod treatment prescribed after natalizumab
Diego Centonze, Silvia Rossi, Francesca Rinaldi, et al.
Page
of 25
Search research articles
Search
Showing results (11-20 of 241) with videos related to
Sort By:
Page
of 25
Prion
|
October 25, 2012
Grey matter lesions in MS: from histology to clinical implications
Massimiliano Calabrese, Alice Favaretto, Valeria Martini, et al.
Expert Review of Neurotherapeutics
|
March 8, 2011
Cortical pathology and cognitive impairment in multiple sclerosis
Massimiliano Calabrese, Francesca Rinaldi, Paola Grossi, et al.
JAMA
|
October 30, 2025
Screening for Hepatitis C in Emergency Departments
Paolo Gallo, Umberto Vespasiani-Gentilucci, Raffaele Antonelli-Incalzi
Frontiers in Neurology
|
June 3, 2021
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities
Monica Margoni, Francesca Rinaldi, Paola Perini, et al.
Expert Review of Neurotherapeutics
|
October 22, 2011
The puzzle of multiple sclerosis: gray matter finds its place
Massimiliano Calabrese, Francesca Rinaldi, Valentina Poretto, et al.
Journal of Neurology
|
March 12, 2004
The clinical impact of interferon beta antibodies in relapsing-remitting MS
Paola Perini, Massimiliano Calabrese, Giovanni Biasi, et al.
Biochemical and Biophysical Research Communications
|
November 13, 2017
Upregulation of eIF6 inhibits cardiac hypertrophy induced by phenylephrine
Nicla Romano, Sara Ricciardi, Paolo Gallo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 4, 2008
Cyclophosphamide-based combination therapies for autoimmunity
Paola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.
Expert Opinion on Drug Safety
|
March 21, 2007
The safety profile of cyclophosphamide in multiple sclerosis therapy
Paola Perini, Massimiliano Calabrese, Luciano Rinaldi, et al.
Neurology
|
October 5, 2012
Severe relapses under fingolimod treatment prescribed after natalizumab
Diego Centonze, Silvia Rossi, Francesca Rinaldi, et al.
Page
of 25